Moreau F, Brunao BB, Liu XY, et al. Liver-specific FGFR4 knockdown in mice on an HFD increases bile acid synthesis and improves hepatic steatosis. Journal of lipid research. 2023;64(2):100324. doi:10.1016/j.jlr.2022.100324
Metabolomics Platform
Phadnis V V, Snider J, Varadharajan V, et al. MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis. Cell reports. 2023;42(9):113023. doi:10.1016/j.celrep.2023.113023
Nagai TH, Hartigan C, Mizoguchi T, et al. Chromatin regulator SMARCAL1 modulates cellular lipid metabolism. Communications biology. 2023;6(1):1298. doi:10.1038/s42003-023-05665-6
Zeleznik OA, Kang JH, Lasky-Su J, et al. Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank. Nature communications. 2023;14(1):2860. doi:10.1038/s41467-023-38466-w
Mayers JR, Varon J, Zhou RR, et al. Identification and targeting of microbial putrescine acetylation in bloodstream infections. bioRxiv : the preprint server for biology. 2023. doi:10.1101/2023.09.21.558834
Semnani-Azad Z, Toledo E, Babio N, et al. Plasma metabolite predictors of metabolic syndrome incidence and reversion. Metabolism: clinical and experimental. 2023;151:155742. doi:10.1016/j.metabol.2023.155742
GarcÃa-Gavilán JF, Babio N, Toledo E, et al. Olive oil consumption, plasma metabolites, and risk of type 2 diabetes and cardiovascular disease. Cardiovascular diabetology. 2023;22(1):340. doi:10.1186/s12933-023-02066-1
Mehta RS, Mayers JR, Zhang Y, et al. Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease. Nature medicine. 2023;29(3):700-709. doi:10.1038/s41591-023-02217-7
Shah R V, Steffen LM, Nayor M, et al. Dietary metabolic signatures and cardiometabolic risk. European heart journal. 2023;44(7):557-569. doi:10.1093/eurheartj/ehac446
Wong WJ, Emdin C, Bick AG, et al. Author Correction: Clonal haematopoiesis and risk of chronic liver disease. Nature. 2023. doi:10.1038/s41586-023-06375-z